603669 灵康药业
已收盘 03-30 15:00:00
资讯
新帖
简况
每周股票复盘:灵康药业(603669)回应业绩预告问询
证券之星 · 03-29 02:57
每周股票复盘:灵康药业(603669)回应业绩预告问询
股市必读:新发布《中审亚太会计师事务所(特殊普通合伙)关于对灵康药业集团股份有限公司业绩预告有关事项的问询函的回复》
证券之星 · 03-26
股市必读:新发布《中审亚太会计师事务所(特殊普通合伙)关于对灵康药业集团股份有限公司业绩预告有关事项的问询函的回复》
生物医药板块午后再度拉升 灵康药业触及涨停
每日经济新闻 · 03-24
生物医药板块午后再度拉升 灵康药业触及涨停
股市必读:灵康药业(603669)3月23日收盘跌6.68%,主力净流出101.48万元
证券之星 · 03-24
股市必读:灵康药业(603669)3月23日收盘跌6.68%,主力净流出101.48万元
每周股票复盘:灵康药业(603669)变更签字会计师及注销891万回购股份
证券之星 · 03-08
每周股票复盘:灵康药业(603669)变更签字会计师及注销891万回购股份
灵康药业(603669)披露关于变更回购股份用途并注销暨减少注册资本的议案,3月5日股价上涨2.09%
证券之星 · 03-05
灵康药业(603669)披露关于变更回购股份用途并注销暨减少注册资本的议案,3月5日股价上涨2.09%
灵康药业(603669)披露变更签字注册会计师公告,3月2日股价下跌3.43%
证券之星 · 03-02
灵康药业(603669)披露变更签字注册会计师公告,3月2日股价下跌3.43%
灵康药业(603669)披露回购股份用途变更公告,2月27日股价上涨1.3%
证券之星 · 02-27
灵康药业(603669)披露回购股份用途变更公告,2月27日股价上涨1.3%
每周股票复盘:灵康药业(603669)2025年净利预亏1.27亿元
证券之星 · 02-08
每周股票复盘:灵康药业(603669)2025年净利预亏1.27亿元
灵康药业(603669)披露2025年度业绩预亏公告,2月6日股价上涨1.3%
证券之星 · 02-06
灵康药业(603669)披露2025年度业绩预亏公告,2月6日股价上涨1.3%
每周股票复盘:灵康药业(603669)拟注销近892万股并减少注册资本
证券之星 · 02-01
每周股票复盘:灵康药业(603669)拟注销近892万股并减少注册资本
灵康药业(603669)披露2025年年度业绩预告,1月23日股价上涨1.24%
证券之星 · 01-23
灵康药业(603669)披露2025年年度业绩预告,1月23日股价上涨1.24%
每周股票复盘:灵康药业(603669)可转债转股新增7806136股
证券之星 · 01-11
每周股票复盘:灵康药业(603669)可转债转股新增7806136股
灵康药业(603669)披露可转债转股结果暨股份变动公告,1月5日股价上涨3.07%
证券之星 · 01-05
灵康药业(603669)披露可转债转股结果暨股份变动公告,1月5日股价上涨3.07%
每周股票复盘:灵康药业(603669)推“提质增效重回报”行动方案
证券之星 · 01-02
每周股票复盘:灵康药业(603669)推“提质增效重回报”行动方案
灵康药业(603669)披露“提质增效重回报”行动方案,12月30日股价下跌0.65%
证券之星 · 2025-12-30
灵康药业(603669)披露“提质增效重回报”行动方案,12月30日股价下跌0.65%
每周股票复盘:灵康药业(603669)股东会通过聘任2025年度审计机构议案
证券之星 · 2025-12-28
每周股票复盘:灵康药业(603669)股东会通过聘任2025年度审计机构议案
灵康药业(603669)公司公告披露聘任2025年度审计机构,12月24日股价下跌0.21%
证券之星 · 2025-12-24
灵康药业(603669)公司公告披露聘任2025年度审计机构,12月24日股价下跌0.21%
灵康药业(603669)披露拟变更2025年度审计机构,12月18日股价上涨1.09%
证券之星 · 2025-12-18
灵康药业(603669)披露拟变更2025年度审计机构,12月18日股价上涨1.09%
灵康药业(603669)披露关于“灵康转债”预计满足转股价格修正条件的提示性公告,12月02日股价下跌0.96%
证券之星 · 2025-12-02
灵康药业(603669)披露关于“灵康转债”预计满足转股价格修正条件的提示性公告,12月02日股价下跌0.96%
加载更多
公司概况
公司名称:
灵康药业集团股份有限公司
所属行业:
医药制造业
上市日期:
2015-05-28
主营业务:
灵康药业集团股份有限公司的主营业务是化药处方药的研发、生产和销售。公司的主要产品有注射用石杉碱甲,注射用维库溴铵,注射用拉氧头孢钠,注射用头孢呋辛钠,注射用头孢美唑钠,注射用氟马西尼,盐酸多巴胺注射液,盐酸艾司洛尔注射液,注射用头孢唑肟钠,注射用氨曲南,丙氨酰谷氨酰胺注射液,左卡尼汀注射液。公司先后获得“中国创新力医药企业”、“中国药品研发综合实力百强榜”等荣誉,灵康制药“一种奥美拉唑钠半水合物及其制备方法”专利荣获中国专利优秀奖,继续保持公司在行业内的竞争优势。
发行价格:
11.70
{"stockData":{"symbol":"603669","market":"SH","secType":"STK","nameCN":"灵康药业","latestPrice":4.57,"timestamp":1774854000000,"preClose":4.51,"halted":0,"volume":10294400,"delay":0,"changeRate":0.0133,"floatShares":721000000,"shares":721000000,"eps":-0.1642,"marketStatus":"已收盘","change":0.06,"latestTime":"03-30 15:00:00","open":4.48,"high":4.58,"low":4.47,"amount":46810800,"amplitude":0.0244,"askPrice":4.57,"askSize":766,"bidPrice":4.56,"bidSize":706,"shortable":0,"etf":0,"ttmEps":-0.1642,"tradingStatus":0,"nextMarketStatus":{"tag":"开盘","tradingStatus":2,"beginTime":1774920600000},"marketStatusCode":5,"adr":0,"adjPreClose":4.51,"symbolType":"stock","openAndCloseTimeList":[[1774834200000,1774841400000],[1774846800000,1774854000000]],"highLimit":4.96,"lowLimit":4.06,"ibTradeSell":true,"ibTradeBuySell":false,"totalEquity":721246136,"isCdr":false,"pbRate":4.88,"roa":"--","roe":"--","epsLYR":-0.18,"committee":-0.601354,"marketValue":3296000000,"turnoverRate":0.0143,"status":0,"floatMarketCap":3296000000},"requestUrl":"/m/hq/s/603669","defaultTab":"news","newsList":[{"id":"2623338382","title":"每周股票复盘:灵康药业(603669)回应业绩预告问询","url":"https://stock-news.laohu8.com/highlight/detail?id=2623338382","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2623338382?lang=zh_cn&edition=full","pubTime":"2026-03-29 02:57","pubTimestamp":1774724228,"startTime":"0","endTime":"0","summary":"截至2026年3月27日收盘,灵康药业报收于4.51元,较上周的4.34元上涨3.92%。本周,灵康药业3月27日盘中最高价报4.51元。本周关注点来自公司公告汇总:灵康药业就上交所关于业绩预告事项的问询函进行回复,披露医药流通业务模式及收入增长原因。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026032900000582.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0239","BK0033","BK0056","603669"],"gpt_icon":0},{"id":"2622100905","title":"股市必读:新发布《中审亚太会计师事务所(特殊普通合伙)关于对灵康药业集团股份有限公司业绩预告有关事项的问询函的回复》","url":"https://stock-news.laohu8.com/highlight/detail?id=2622100905","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2622100905?lang=zh_cn&edition=full","pubTime":"2026-03-26 03:00","pubTimestamp":1774465242,"startTime":"0","endTime":"0","summary":"中审亚太会计师事务所关于对灵康药业集团股份有限公司业绩预告有关事项的问询函的回复灵康药业集团股份有限公司就上海证券交易所关于其业绩预告有关事项的问询函作出回复,涉及医药流通业务、心脑血管类产品营业收入、与湖南丰恺思及湖南佰家康的业务模式、市场营销服务费等事项。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026032600003024.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0056","BK0239","603669","BK0033"],"gpt_icon":0},{"id":"2621055153","title":"生物医药板块午后再度拉升 灵康药业触及涨停","url":"https://stock-news.laohu8.com/highlight/detail?id=2621055153","media":"每日经济新闻","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2621055153?lang=zh_cn&edition=full","pubTime":"2026-03-24 13:17","pubTimestamp":1774329420,"startTime":"0","endTime":"0","summary":"每经AI快讯,3月24日,生物医药板块午后再度拉升,灵康药业(维权)触及涨停,迪哲医药、共同药业、苑东生物、诚意药业跟涨。\n\n\n海量资讯、精准解读,尽在新浪财经APP","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"sina","url":"https://finance.sina.com.cn/stock/relnews/cn/2026-03-24/doc-inhsaeyx3555839.shtml","rn_cache_url":null,"customStyle":"body{padding-top:10px;}.art_tit_h1{#titleStyle#}a{#lv2TextColor#}.art_time, .art_cite{#sourceStyle#;} .art_cite{margin-left: 3px;}","selectors":".module-article, article","filters":"header, .voice2, .tags, #norm_qrcode_link_auto, .unfold-box, .action","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.sina.com.cn/stock/relnews/cn/2026-03-24/doc-inhsaeyx3555839.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"sina","symbols":["BK4585","BK0239","BK0056","399441","BK4581","BK4588","BK0033","161726","XBI","603669"],"gpt_icon":0},{"id":"2621082530","title":"股市必读:灵康药业(603669)3月23日收盘跌6.68%,主力净流出101.48万元","url":"https://stock-news.laohu8.com/highlight/detail?id=2621082530","media":"证券之星","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2621082530?lang=zh_cn&edition=full","pubTime":"2026-03-24 04:42","pubTimestamp":1774298533,"startTime":"0","endTime":"0","summary":"截至2026年3月23日收盘,灵康药业报收于4.05元,下跌6.68%,换手率1.4%,成交量10.07万手,成交额4176.6万元。当日关注点来自交易信息汇总:灵康药业3月23日收盘报4.05元,跌6.68%,已连续3日下跌。来自资金流向:3月23日主力资金净流出101.48万元,占总成交额2.43%。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026032400005171.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["603669","BK0239","BK0033","BK0056"],"gpt_icon":0},{"id":"2617663597","title":"每周股票复盘:灵康药业(603669)变更签字会计师及注销891万回购股份","url":"https://stock-news.laohu8.com/highlight/detail?id=2617663597","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2617663597?lang=zh_cn&edition=full","pubTime":"2026-03-08 03:08","pubTimestamp":1772910493,"startTime":"0","endTime":"0","summary":"截至2026年3月6日收盘,灵康药业报收于4.57元,较上周的4.66元下跌1.93%。本周,灵康药业3月2日盘中最高价报4.68元。公司公告汇总:股东会通过变更回购股份用途并注销议案,拟注销8,915,893股减少注册资本。本次变更不会对公司2025年度审计工作产生不利影响。表决结果为同意310,174,161股,占99.8275%;反对405,752股,占0.1305%;弃权129,948股,占0.0420%。注销后,公司总股本拟由721,246,136股变更为712,330,243股,注册资本相应减少。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026030800001083.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0239","BK0033","BK0056","603669"],"gpt_icon":0},{"id":"2617525925","title":"灵康药业(603669)披露关于变更回购股份用途并注销暨减少注册资本的议案,3月5日股价上涨2.09%","url":"https://stock-news.laohu8.com/highlight/detail?id=2617525925","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2617525925?lang=zh_cn&edition=full","pubTime":"2026-03-05 22:29","pubTimestamp":1772720956,"startTime":"0","endTime":"0","summary":"近日,灵康药业集团股份有限公司披露《关于回购账户部分股份注销通知债权人的公告》。公告显示,公司于2026年3月5日召开2026年第一次临时股东会,审议通过《关于变更回购股份用途并注销暨减少注册资本的议案》。公司将回购专用账户中尚未使用的8,915,893股股份由原定用于员工持股计划和股权激励变更为全部注销,减少注册资本。注销后,公司总股本拟由721,246,136股变更为712,330,243股,注册资本相应减少。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026030500039555.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["603669","BK0033","BK0056","BK0239"],"gpt_icon":0},{"id":"2616356933","title":"灵康药业(603669)披露变更签字注册会计师公告,3月2日股价下跌3.43%","url":"https://stock-news.laohu8.com/highlight/detail?id=2616356933","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2616356933?lang=zh_cn&edition=full","pubTime":"2026-03-02 23:02","pubTimestamp":1772463753,"startTime":"0","endTime":"0","summary":"截至2026年3月2日收盘,灵康药业报收于4.5元,较前一交易日下跌3.43%,最新总市值为32.46亿元。近日,灵康药业集团股份有限公司发布《关于变更签字注册会计师的公告》。公告显示,公司原聘任中审亚太会计师事务所吴军、于伟为2025年度签字注册会计师,因吴军工作调整,现变更为于伟、张财峰为签字注册会计师。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026030200040292.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0239","603669","BK0033","BK0056"],"gpt_icon":0},{"id":"2614857572","title":"灵康药业(603669)披露回购股份用途变更公告,2月27日股价上涨1.3%","url":"https://stock-news.laohu8.com/highlight/detail?id=2614857572","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2614857572?lang=zh_cn&edition=full","pubTime":"2026-02-27 23:02","pubTimestamp":1772204543,"startTime":"0","endTime":"0","summary":"截至2026年2月27日收盘,灵康药业报收于4.66元,较前一交易日上涨1.3%,最新总市值为33.61亿元。近日,灵康药业集团股份有限公司发布《2026年第一次临时股东会会议资料》公告,拟将已回购但尚未使用的8,915,893股股份用途由‘50%用于员工持股计划,50%用于股权激励’变更为‘用于注销并减少注册资本’。本次回购股份已于2023年1月9日完成,累计回购股份占公司总股本的1.2362%。注销后公司总股本将由721,246,136股变更为712,330,243股,注册资本相应减少。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026022700042954.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["603669","BK0239","BK0033","BK0056"],"gpt_icon":0},{"id":"2609483526","title":"每周股票复盘:灵康药业(603669)2025年净利预亏1.27亿元","url":"https://stock-news.laohu8.com/highlight/detail?id=2609483526","media":"证券之星","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2609483526?lang=zh_cn&edition=full","pubTime":"2026-02-08 03:10","pubTimestamp":1770491421,"startTime":"0","endTime":"0","summary":"截至2026年2月6日收盘,灵康药业报收于4.68元,较上周的4.56元上涨2.63%。本周,灵康药业2月6日盘中最高价报4.72元。灵康药业预计2025年归属于母公司所有者的净利润为-12700万元左右,同比减亏2.88%;扣除非经常性损益后的净利润为-14700万元左右,同比减亏18.41%。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026020800001137.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-2","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0239","BK0033","BK0056","603669"],"gpt_icon":0},{"id":"2609948815","title":"灵康药业(603669)披露2025年度业绩预亏公告,2月6日股价上涨1.3%","url":"https://stock-news.laohu8.com/highlight/detail?id=2609948815","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2609948815?lang=zh_cn&edition=full","pubTime":"2026-02-06 22:25","pubTimestamp":1770387923,"startTime":"0","endTime":"0","summary":"截至2026年2月6日收盘,灵康药业报收于4.68元,较前一交易日上涨1.3%,最新总市值为33.75亿元。该股当日开盘4.61元,最高4.72元,最低4.61元,成交额达3500.17万元,换手率为1.04%。近日,东方金诚国际信用评估有限公司发布关于灵康药业集团股份有限公司2025年度业绩预亏的关注公告。灵康药业预计2025年归属于母公司所有者的净利润为-12700万元左右,同比减亏2.88%;扣除非经常性损益后的净利润为-14700万元左右,同比减亏18.41%;营业收入预计为36500万元左右,同比下降3.89%。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026020600041093.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["603669","BK0056","BK0239","BK0033"],"gpt_icon":0},{"id":"2608070885","title":"每周股票复盘:灵康药业(603669)拟注销近892万股并减少注册资本","url":"https://stock-news.laohu8.com/highlight/detail?id=2608070885","media":"证券之星","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2608070885?lang=zh_cn&edition=full","pubTime":"2026-02-01 03:39","pubTimestamp":1769888349,"startTime":"0","endTime":"0","summary":"截至2026年1月30日收盘,灵康药业报收于4.56元,较上周的4.88元下跌6.56%。本周关注点公司公告汇总:灵康药业拟将已回购的8,915,893股股份全部用于注销并减少注册资本。本次注销后,公司总股本将由721,246,136股变更为712,330,243股,注册资本相应减少。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026020100001248.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["603669","BK0056","BK0239","BK0033"],"gpt_icon":0},{"id":"2605860409","title":"灵康药业(603669)披露2025年年度业绩预告,1月23日股价上涨1.24%","url":"https://stock-news.laohu8.com/highlight/detail?id=2605860409","media":"证券之星","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2605860409?lang=zh_cn&edition=full","pubTime":"2026-01-23 22:56","pubTimestamp":1769180172,"startTime":"0","endTime":"0","summary":"截至2026年1月23日收盘,灵康药业报收于4.88元,较前一交易日上涨1.24%,最新总市值为35.2亿元。该股当日开盘4.85元,最高4.91元,最低4.8元,成交额达3979.16万元,换手率为1.13%。近日,灵康药业集团股份有限公司披露2025年年度业绩预告。公告显示,公司预计2025年年度归属于母公司所有者的净利润为-12,700万元左右,同比减亏2.88%;扣除非经常性损益后的净利润为-14,700万元左右,同比减亏18.41%。营业收入预计为36,500万元左右,同比下降3.89%。该业绩预告未经注册会计师审计。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026012300043511.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["603669","BK0033","BK0056","BK0239"],"gpt_icon":0},{"id":"2602153577","title":"每周股票复盘:灵康药业(603669)可转债转股新增7806136股","url":"https://stock-news.laohu8.com/highlight/detail?id=2602153577","media":"证券之星","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2602153577?lang=zh_cn&edition=full","pubTime":"2026-01-11 03:25","pubTimestamp":1768073109,"startTime":"0","endTime":"0","summary":"截至2026年1月9日收盘,灵康药业报收于4.81元,较上周的4.56元上涨5.48%。本周,灵康药业1月9日盘中最高价报4.82元。灵康药业当前最新总市值34.69亿元,在化学制药板块市值排名126/150,在两市A股市值排名4346/5182。截至2025年12月31日,累计67,205,000元可转债转换为7,806,136股,占转股前总股本的1.0942%。股本结构中无限售条件流通股相应增加,总股本同步变动。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026011100000970.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["603669","BK0239","BK0033","BK0056"],"gpt_icon":0},{"id":"2601000415","title":"灵康药业(603669)披露可转债转股结果暨股份变动公告,1月5日股价上涨3.07%","url":"https://stock-news.laohu8.com/highlight/detail?id=2601000415","media":"证券之星","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2601000415?lang=zh_cn&edition=full","pubTime":"2026-01-05 18:29","pubTimestamp":1767608970,"startTime":"0","endTime":"0","summary":"截至2026年1月5日收盘,灵康药业报收于4.7元,较前一交易日上涨3.07%,最新总市值为33.9亿元。近日,灵康药业集团股份有限公司发布可转债转股结果暨股份变动公告。2025年10月1日至12月31日期间,灵康转债转股金额为1,000元,转股数量为153股,占转股前总股本的0.000021%。截至2025年12月31日,累计67,205,000元可转债转换为7,806,136股,占转股前总股本的1.0942%。股本结构中无限售条件流通股相应增加,总股本同步变动。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026010500029046.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0033","603669","BK0056","BK0239"],"gpt_icon":0},{"id":"2600362640","title":"每周股票复盘:灵康药业(603669)推“提质增效重回报”行动方案","url":"https://stock-news.laohu8.com/highlight/detail?id=2600362640","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2600362640?lang=zh_cn&edition=full","pubTime":"2026-01-02 03:18","pubTimestamp":1767295093,"startTime":"0","endTime":"0","summary":"截至2025年12月26日收盘,灵康药业报收于4.66元,较上周的4.72元下跌1.27%。本周,灵康药业12月23日盘中最高价报4.87元。灵康药业当前最新总市值32.89亿元,在化学制药板块市值排名127/150,在两市A股市值排名4363/5181。本周关注点来自公司公告汇总:灵康药业发布“提质增效重回报”行动方案,聚焦主业与投资者回报。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026010200000858.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0239","BK0056","603669","BK0033"],"gpt_icon":0},{"id":"2595718743","title":"灵康药业(603669)披露“提质增效重回报”行动方案,12月30日股价下跌0.65%","url":"https://stock-news.laohu8.com/highlight/detail?id=2595718743","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2595718743?lang=zh_cn&edition=full","pubTime":"2025-12-30 22:34","pubTimestamp":1767105259,"startTime":"0","endTime":"0","summary":"截至2025年12月30日收盘,灵康药业报收于4.6元,较前一交易日下跌0.65%,最新总市值为33.18亿元。该股当日开盘4.61元,最高4.63元,最低4.54元,成交额达2109.55万元,换手率为0.64%。近日,灵康药业集团股份有限公司发布关于‘提质增效重回报’行动方案的公告。公告显示,公司为提升经营质量、增强投资者回报,制定该行动方案。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025123000044460.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0033","BK0239","603669","BK0056"],"gpt_icon":0},{"id":"2594247136","title":"每周股票复盘:灵康药业(603669)股东会通过聘任2025年度审计机构议案","url":"https://stock-news.laohu8.com/highlight/detail?id=2594247136","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2594247136?lang=zh_cn&edition=full","pubTime":"2025-12-28 05:19","pubTimestamp":1766870351,"startTime":"0","endTime":"0","summary":"截至2025年12月26日收盘,灵康药业报收于4.66元,较上周的4.72元下跌1.27%。本周,灵康药业12月23日盘中最高价报4.87元。本次股东会由董事会召集,于2025年12月24日以现场与网络投票方式召开,审议通过《关于聘任2025年度审计机构的议案》。会议审议通过了关于聘任2025年度审计机构的议案,表决结果为同意310,123,299股,占出席会议有表决权股份的99.5714%。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025122800001438.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0239","BK0056","BK0033","603669"],"gpt_icon":0},{"id":"2593408824","title":"灵康药业(603669)公司公告披露聘任2025年度审计机构,12月24日股价下跌0.21%","url":"https://stock-news.laohu8.com/highlight/detail?id=2593408824","media":"证券之星","labels":["executive"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2593408824?lang=zh_cn&edition=full","pubTime":"2025-12-24 22:43","pubTimestamp":1766587397,"startTime":"0","endTime":"0","summary":"截至2025年12月24日收盘,灵康药业报收于4.66元,较前一交易日下跌0.21%,最新总市值为33.61亿元。该股当日开盘4.68元,最高4.7元,最低4.63元,成交额达3247.64万元,换手率为0.97%。近日,灵康药业集团股份有限公司召开2025年第三次临时股东会,审议通过《关于聘任2025年度审计机构的议案》。公告显示,出席会议的股东及代理人共212人,代表有表决权股份总数的44.2699%。议案表决结果为同意310,123,299股,占出席会议有表决权股份的99.5714%。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025122400041382.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"executive","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0033","BK0056","603669","BK0239"],"gpt_icon":0},{"id":"2592904734","title":"灵康药业(603669)披露拟变更2025年度审计机构,12月18日股价上涨1.09%","url":"https://stock-news.laohu8.com/highlight/detail?id=2592904734","media":"证券之星","labels":["executive"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2592904734?lang=zh_cn&edition=full","pubTime":"2025-12-18 22:27","pubTimestamp":1766068075,"startTime":"0","endTime":"0","summary":"截至2025年12月18日收盘,灵康药业报收于4.62元,较前一交易日上涨1.09%,最新总市值为33.32亿元。该股当日开盘4.56元,最高4.67元,最低4.52元,成交额达3927.09万元,换手率为1.18%。近日,灵康药业集团股份有限公司发布2025年第三次临时股东会会议资料,宣布拟聘任中审亚太会计师事务所为2025年度财务报表及内部控制审计机构,原聘任的会计师事务所为中审众环会计师事务所。2025年度审计费用为85万元,其中财务审计60万元,内控审计25万元,与上年持平。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025121800038911.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"executive","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0056","BK0239","603669","BK0033"],"gpt_icon":0},{"id":"2588039447","title":"灵康药业(603669)披露关于“灵康转债”预计满足转股价格修正条件的提示性公告,12月02日股价下跌0.96%","url":"https://stock-news.laohu8.com/highlight/detail?id=2588039447","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2588039447?lang=zh_cn&edition=full","pubTime":"2025-12-02 17:53","pubTimestamp":1764669199,"startTime":"0","endTime":"0","summary":"截至2025年12月2日收盘,灵康药业报收于5.17元,较前一交易日下跌0.96%,最新总市值为37.29亿元。该股当日开盘5.21元,最高5.21元,最低5.11元,成交额达2733.39万元,换手率为0.74%。近日,灵康药业集团股份有限公司发布关于“灵康转债”预计满足转股价格修正条件的提示性公告。若在任意连续三十个交易日内有至少十五个交易日收盘价低于该阈值,将触发修正条件。公司将在触发当日召开董事会审议是否修正转股价格,并及时披露相关信息。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025120200027041.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["603669","BK0033","BK0239","BK0056"],"gpt_icon":0}],"profile":{"ret":0,"serverTime":1774861861567,"stockEarnings":[{"period":"1week","weight":0.0392},{"period":"1month","weight":-0.0465},{"period":"3month","weight":-0.0322},{"period":"6month","weight":-0.1975},{"period":"1year","weight":0.0067},{"period":"ytd","weight":-0.011}],"compareEarnings":[{"period":"1week","weight":-0.011},{"period":"1month","weight":-0.0563},{"period":"3month","weight":-0.0126},{"period":"6month","weight":0.0224},{"period":"1year","weight":0.1601},{"period":"ytd","weight":-0.0139}],"compareStock":{"symbol":"000001.SH","name":"上证指数"},"companyName":"灵康药业集团股份有限公司","boardCode":"AI0027","boardName":"医药制造业","stockholders":"25212人(较上一季度增加32.60%)","perCapita":"28607股","listingDate":"2015-05-28","address":"西藏自治区山南市乃东区国道349号(结巴乡段)20号","registeredCapital":"72124万元","survey":" 灵康药业集团股份有限公司的主营业务是化药处方药的研发、生产和销售。公司的主要产品有注射用石杉碱甲,注射用维库溴铵,注射用拉氧头孢钠,注射用头孢呋辛钠,注射用头孢美唑钠,注射用氟马西尼,盐酸多巴胺注射液,盐酸艾司洛尔注射液,注射用头孢唑肟钠,注射用氨曲南,丙氨酰谷氨酰胺注射液,左卡尼汀注射液。公司先后获得“中国创新力医药企业”、“中国药品研发综合实力百强榜”等荣誉,灵康制药“一种奥美拉唑钠半水合物及其制备方法”专利荣获中国专利优秀奖,继续保持公司在行业内的竞争优势。","listedPrice":11.7},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"tenantId":"TBCN","deviceId":"web-server-community-laohu8-v3","version":"4.38.0","shortVersion":"4.38.0","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"灵康药业(603669)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供灵康药业(603669)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"灵康药业,603669,灵康药业股票,灵康药业股票老虎,灵康药业股票老虎国际,灵康药业行情,灵康药业股票行情,灵康药业股价,灵康药业股市,灵康药业股票价格,灵康药业股票交易,灵康药业股票购买,灵康药业股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"灵康药业(603669)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供灵康药业(603669)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}